BRAINLIFE.ORG





Current Neuro-Oncology




Volume 26 Number 22
10 October 2024




Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 22, 10 October






Chainey J, Kim MJ, Chan VK, Au K.
Patient experiences in high-grade gliomas: from symptoms to radiotherapy.
BMJ Support Palliat Care. 2024 Oct 1:spcare-2023-004659. doi: 10.1136/spcare-2023-004659. PMID: 39353720. Observational study˰ ˍ




Zeyen T, Böhm L, Paech D, Schäfer N, Tzaridis T, Duffy C, Nitsch L, Schneider M, Potthoff AL, Schneider-Rothhaar JL, Steinbach JP, Hau P, Kowalski T, Seidel C, Krex D, Grauer O, Goldbrunner R, Zeiner PS, Tabatabai G, Galldiks N, Stummer W, Hattingen E, Glas M, Gkika E, Vatter H, Radbruch A, Herrlinger U, Weller J, Schaub C.
Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ.
Neuro Oncol. 2024 Oct 1:noae205. doi: 10.1093/neuonc/noae205. PMID: 39351820. Observational study˰ ˍ




Cai T, Jin T, Guan Y, Zou W, Wang X, Zhu Y.
Hyperbaric oxygen therapy enhances restoration of physical functional in patients with recurrent glioma: A case report.
Oncol Lett. 2024 Oct 2;28(6):583. doi: 10.3892/ol.2024.14716. PMID: 39421317. Case report. ˍ




Haisraely O, Taliansky A, Sivan M, Lawerence Y.
Re-irradiation of anaplastic meningioma: higher dose and concomitant Bevacizumab may improve progression-free survival.
Radiat Oncol. 2024 Oct 2;19(1):135. doi: 10.1186/s13014-024-02486-7. PMID: 39358739. Observational study. ˍ




Kacimi SEO, Dehais C, Feuvret L, Chinot O, Carpentier C, Bronnimann C, Vauleon E, Djelad A, Cohen-Jonathan Moyal E, Langlois O, Campone M, Ducloie M, Noel G, Cuzzubbo S, Taillandier L, Ramirez C, Younan N, Menei P, Dhermain F, Desenclos C, Ghiringhelli F, Bourg V, Ricard D, Faillot T, Appay R, Tabouret E, Nichelli L, Mathon B, Thomas A, Tran S, Bielle F, Alentorn A, Iorgulescu JB, Boëlle PY, Labreche K, Hoang-Xuan K, Sanson M, Idbaih A, Figarella-Branger D, Ducray F, Touat M; POLA Network.
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.
J Clin Oncol. 2024 Oct 2:JCO2400049. doi: 10.1200/JCO.24.00049. PMID: 39356975. Observational study˰ ˍ




*Yi Y, Che W, Xu P, Mao C, Li Z, Wang Q, Lyu J, Wang X.
Conversion of glioma cells into neuron-like cells by small molecules.
iScience. 2024 Oct 2;27(11):111091. doi: 10.1016/j.isci.2024.111091. PMID: 39483145. Laboratory investigation. ˍ




Götz L, Ansafi T, Gerken M, Klinkhammer-Schalke M, Fischl A, Riemenschneider MJ, Proescholdt M, Bumes E, Kölbl O, Schmidt NO, Linker R, Hau P, Haedenkamp TM.
Effect of antibiotic drug use on outcome and therapy-related toxicity in patients with glioblastoma-A retrospective cohort study.
Neurooncol Adv. 2024 Oct 4;6(1):vdae170. doi: 10.1093/noajnl/vdae170. PMID: 39493414. Observational study. ˍ




Ghimire P, Kamaludin A, Palau BF, Lavrador JP, Gullan R, Vergani F, Bhangoo R, Ashkan K.
MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study.
Acta Neurochir (Wien). 2024 Oct 5;166(1):394. doi: 10.1007/s00701-024-06300-x. PMID: 39367282. Observational study. ˍ




Huang Y, Shan Y, Zhang W, Printzis C, Pesce L, Maeser D, Stanhope C, Stranger BE, Huang RS.
Sex differences in the molecular profile of adult diffuse glioma are shaped by IDH status and tumor microenvironment.
Neuro Oncol. 2024 Oct 5:noae207. doi: 10.1093/neuonc/noae207. PMID: 39367624. Observational study˰ ˍ




Li Z, Lin Z, Liu H, Xiao R, Lin C, Zhu W, Luo J, Xu S, Chi F, He H.
Treatment Continuity and Bone Marrow Suppression in Whole-Brain and Whole-Spinal Cord Radiotherapy for Medulloblastoma Patients.
Clin Med Insights Oncol. 2024 Oct 5;18:11795549241286431. doi: 10.1177/11795549241286431. PMID: 39371257. Observational study. ˍ




Luo Y, Gadd ME, Qie Y, Otamendi-Lopez A, Sanchez-Garavito JE, Brooks MM, Ulloa Navas MJ, Hundal T, Li S, Jones VK, Lou Y, Patel T, Dronca R, Kharfan-Dabaja MA, Dong H, Quinones-Hinojosa A, Qin H.
Solid cancer-directed CAR T cell therapy that attacks both tumor and immunosuppressive cells via targeting PD-L1.
Mol Ther Oncol. 2024 Oct 5;32(4):200891. doi: 10.1016/j.omton.2024.200891. PMID: 39498357. Laboratory investigation. ˍ




Huangfu L, Zha B, Li P, Wang L, Liu X, Cui H, Li Y, Wu J, Shi S, Yang Y, Sun X, Gao S, Li H, Yang D, Zheng Y.
A phase I clinical trial of sonodynamic therapy combined with radiotherapy for brainstem gliomas.
Int J Cancer. 2024 Oct 8. doi: 10.1002/ijc.35218. PMID: 39377640. Interventional study˰ ˍ




*Price M, Ballard C, Benedetti J, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS, Ostrom QT.
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2017-2021.
Neuro Oncol. 2024 Oct 6;26(Supplement_6):vi1-vi85. doi: 10.1093/neuonc/noae145. PMID: 39371035. Observational study. ˍ




*Schwalbe EC, Lindsey JC, Danilenko M, Hill RM, Crosier S, Ryan SL, Williamson D, Castle J, Hicks D, Kool M, Milde T, Korshunov A, Pfister SM, Bailey S, Clifford SC.
Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort study.
Neuro Oncol. 2024 Oct 8:noae178. doi: 10.1093/neuonc/noae178. PMID: 39377358. Observational study. ˍ




Shen H, Mei Q, Chai X, Jiang Y, Liu A, Liu J.
The prognostic significance of synchronous metastasis in glioblastoma multiforme patients: a propensity score-matched analysis using SEER data.
Front Neurol. 2024 Oct 8;15:1429826. doi: 10.3389/fneur.2024.1429826. PMID: 39440248. Observational study. ˍ




Gao L, Li Y, Zhu H, Liu Y, Li S, Li L, Zhang J, Shen N, Zhu W.
Application of preoperative advanced diffusion magnetic resonance imaging in evaluating the postoperative recurrence of lower grade gliomas.
Cancer Imaging. 2024 Oct 9;24(1):134. doi: 10.1186/s40644-024-00782-9. PMID: 39385297. Observational study. ˍ




Luckett T, DiGiacomo M, Heneka N, Disalvo D, Garcia M, Schaeffer I, Attwood R, Phillips J.
A qualitative study of specialist multidisciplinary clinician perspectives on barriers/facilitators to care for children with brain cancer and their families: "We're a little bit different to our adult counterparts".
Palliat Support Care. 2024 Oct 9:1-6. doi: 10.1017/S1478951524001421. PMID: 39379286. Observational study. ˍ




*Rincon-Torroella J, Rakovec M, Kalluri AL, Jiang K, Weber-Levine C, Parker M, Raj D, Materi J, Sepehri S, Ferres A, Schreck KC, Aldecoa I, Lucas CG, Sair HI, Redmond KJ, Holdhoff M, Weingart J, Brem H, Sánchez JJG, Ye X, Bettegowda C.
Impact of upfront adjuvant chemoradiation on survival in patients with molecularly defined oligodendroglioma: the benefits of PCV over TMZ.
J Neurooncol. 2024 Oct 9. doi: 10.1007/s11060-024-04829-6. PMID: 39382617. Observational study˰ ˍ




Sun MN, Li SQ, Guo Y, Zhou JF, Fu DD, Hua XY, Yu XJ, Lai MY, Cai LB, Shi CZ.
Clinicopathological, immunohistochemical and therapeutic approaches on survival in patients with epithelioid glioblastoma: Institutional experience in the management of 58 patients.
Neurosurg Rev. 2024 Oct 9;47(1):763. doi: 10.1007/s10143-024-02957-1. PMID: 39382734. Observational study. ˍ




Griessmair M, Schramm S, Ziegenfeuter J, Canisius J, Jung K, Delbridge C, Schmidt-Graf F, Mitsdoerffer M, Zimmer C, Meyer B, Metz MC, Wiestler B.
Advanced imaging reveals enhanced malignancy in glioblastomas involving the subventricular zone: evidence of increased infiltrative growth and perfusion.
J Neurooncol. 2024 Oct 10. doi: 10.1007/s11060-024-04849-2. PMID: 39387957. Observational study. ˍ




Lucas Calduch A, Macià Garau M, Villà Freixa S, García Expósito N, Modolell Farré I, Majós Torró C, Pons Escoda A, Mesía Barroso C, Vilariño Quintela N, Rosselló Gómez A, Plans Ahicart G, Martínez García M, Esteve Gómez A, Bruna Escuer J.
Salvage reirradiation for recurrent glioblastoma: a retrospective case series analysis.
Clin Transl Oncol. 2024 Oct 10. doi: 10.1007/s12094-024-03750-8. PMID: 39388047. Observational study˰ ˍ




Valerio JE, Wolf AL, Mantilla-Farfan P, Aguirre Vera GJ, Fernández-Gómez MP, Alvarez-Pinzon AM.
Efficacy and Cognitive Outcomes of Gamma Knife Radiosurgery in Glioblastoma Management for Elderly Patients.
J Pers Med. 2024 Oct 10;14(10):1049. doi: 10.3390/jpm14101049. PMID: 39452556. Observational study. ˍ